IL2 and melanoma: A more promising procedure has been proposed in melanoma where tumor-infiltrating T lymphocytes (TILs) isolated from the tumor tissue used for PDX generation were expanded in vitro by human interleukin 2 (IL2) before injection in tumor-bearing PDX mice [70].